Stay alert, beware of scamsters - know more

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open924.5
High938.7
Low916.3
Prev. Close926.25
Avg. Traded Price930.1
Volume1,58,398

MARKET DEPTH

info2
Total bid0.00
Total ask148.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
926.258148
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

916.303 hours ago
938.709 hours ago
arrow

LOWER/UPPER CIRCUITS

739.80
1109.60
arrow
Jubilant Pharmova Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 14.46%, in the last year to ₹8,345.6 Cr. Its sector's average revenue growth for the last fiscal year was 12.13%.
notePrice to Earning Ratio,is 36.96, lower than its sector PE ratio of 44.99.
noteQuarterly Revenue,rose 18.73% YoY to ₹2,313.7 Cr. Its sector's average revenue growth YoY for the quarter was 15.69%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : -3.03%
Net profit growth 5Y CAGR : -39.03%
Jubilant Pharmova Ltd Top mutual funds holding
arrow

Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses. With a solid network of radio-pharmacies in the US, Jubilant’s Radiopharma business is engaged in manufacturing and supply of Radiopharmaceutical products and services. Its other businesses such as Allergy Immunotherapy, Contract Manufacturing of Sterile Injectables and Non-sterile products and Generics (Solid Dosage Formulations) caters to major regulated markets (USA, EU and other geographies) through five manufacturing facilities.

The CRDMO segment (through Jubilant Biosys) provides collaborative research and partnership for Drug Discovery through two world class research centers in India. The company is also involved in the manufacturing of Active Pharmaceutical Products (API) through a US FDA approved facility in Nanjangud, Karnataka.

personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

For Q4 FY26, Jubilant Pharmova Ltd reported: Revenue (Net Sales): ₹703.00 Cr - Up 4.46% year-on-year from ₹673.00 Cr in Q3 FY26. Net Income (PAT): ₹572.00 Cr - Up 766.67% year-on-year from ₹66.00 Cr in Q3 FY26.

As of 06 Aug 2026, the share price of Jubilant Pharmova Ltd is ₹928.00 on the NSE and ₹927.25 on the BSE. The stock opened at ₹924.50, touched a high of ₹940.00 and a low of ₹910.60 during today's session.

Over the last 6 months, Jubilant Pharmova Ltd has given a return of -1.38%. The stock was priced at ₹937.65 on 06 Feb 2026 and has Fallen to ₹928.00 as of 06 Aug 2026, a change of ₹9.65 per share.

The intraday low for Jubilant Pharmova Ltd on the NSE today was ₹910.60. The stock's 52-week low stands at ₹786.05, recorded on 09 Mar 2026. Today's low is 15.85% above the 52-week low, indicating the stock is trading well above its yearly lows.

The intraday high for Jubilant Pharmova Ltd on the NSE today (06 Aug 2026) was ₹940.00. This compares to the 52-week high of ₹1,184.80 recorded on 21 Oct 2025. Today's high was -20.66% below the 52-week high.

Jubilant Pharmova Ltd has delivered a return of -3.32% over the last 3 months. The stock was trading at ₹956.50 on 06 May 2026 and is currently at ₹928.00 as of 06 Aug 2026, reflecting a Loss of ₹28.50 per share over this period.

Jubilant Pharmova Ltd has delivered -16.28% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,184.80 on 21 Oct 2025 and a 52-week low of ₹786.05 on 09 Mar 2026. It is currently trading at ₹928.00 as of 06 Aug 2026.

The all-time high (ATH) for Jubilant Pharmova Ltd was ₹1,262.60, recorded on 01 Nov 2024. At the current price of ₹928.00, the stock is trading 26.50% below its all-time high. The all-time low recorded was ₹68.35 on 04 Sep 2013.

Jubilant Pharmova Ltd has delivered a 38.49% absolute return over the past 5 years, equivalent to a CAGR of 6.73% per annum. The stock was priced at ₹670.08 in Aug 2021 and has risen to ₹928.00 as of 06 Aug 2026. An investment of ₹1,00,000 in Jubilant Pharmova Ltd five years ago would be worth ₹1,38,490.00 today.

Yes,Jubilant Pharmova Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 25.00 per share between FY2022 and FY2026, with the most recent dividend of ₹5.00 per share for May 26, with an ex-dividend date of 24 Jul 2026. At the current market price of ₹928.00, the trailing dividend yield of Jubilant Pharmova Ltd stands at 10.00%.

+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91